FHIR © HL7.org  |  FHIRsmith 0.14.2  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.medikation
Resource TypeMedicationRequest
IdMedicationRequest-mii-exa-medikation-medication-request-caelyx.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: MedicationRequest mii-exa-medikation-medication-request-caelyx

R5: Full representation of the dosage instructions (new):

Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion

status: Active

intent: Order

medication: Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1

subject: Max Mustermann Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)

authoredOn: 2021-12-21 11:41:00+0100

dosageInstruction

timing: Once per 4 weeks

route: Intravenous use

DoseAndRates

-Dose[x]
*50 mg/m2 BSA (Details: UCUM codemg/m2 = 'mg/m2')

German


Generated Narrative: MedicationRequest mii-exa-medikation-medication-request-caelyx

R5: Full representation of the dosage instructions (new):

Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion

status: Active

intent: Order

medication: Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1

subject: Max Mustermann Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)

authoredOn: 2021-12-21 11:41:00+0100

dosageInstruction

timing: Once per 4 weeks

route: Intravenous use

DoseAndRates

-Dose[x]
*50 mg/m2 BSA (Details: UCUM codemg/m2 = 'mg/m2')

Source1

{
  "resourceType": "MedicationRequest",
  "id": "mii-exa-medikation-medication-request-caelyx",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/MedicationRequest|2027.0.0-ballot"
    ],
    "security": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST",
        "display": "test health data"
      }
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationRequest.renderedDosageInstruction",
      "valueMarkdown": "Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion"
    }
  ],
  "status": "active",
  "intent": "order",
  "medicationReference": {
    "reference": "Medication/mii-exa-medikation-medication-caelyx"
  },
  "subject": {
    "reference": "Patient/mii-exa-medikation-patient"
  },
  "authoredOn": "2021-12-21T11:41:00+01:00",
  "dosageInstruction": [
    {
      "timing": {
        "repeat": {
          "frequency": 1,
          "period": 4,
          "periodUnit": "wk"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://standardterms.edqm.eu",
            "code": "20045000",
            "display": "Intravenous use"
          }
        ]
      },
      "doseAndRate": [
        {
          "doseQuantity": {
            "value": 50,
            "unit": "mg/m2 BSA",
            "system": "http://unitsofmeasure.org",
            "code": "mg/m2"
          }
        }
      ]
    }
  ]
}